scholarly article | Q13442814 |
P50 | author | Timothy R. Card | Q54139253 |
Matthew J. Grainge | Q55292943 | ||
Masoud Solaymani-Dodaran | Q104468413 | ||
Joe West | Q42209694 | ||
Guruprasad P. Aithal | Q42780517 | ||
P2860 | cites work | The UK General Practice Research Database | Q77357717 |
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study | Q79835026 | ||
Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis | Q81100678 | ||
Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001 | Q24651526 | ||
Cigarette smoking, alcohol drinking and the risk of gallbladder cancer death: a prospective cohort study in Japan | Q28254361 | ||
Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy | Q33957032 | ||
Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies | Q34253944 | ||
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study | Q36154934 | ||
Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines | Q36179852 | ||
The General Practice Research Database: quality of morbidity data | Q36858191 | ||
Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database | Q37340253 | ||
Risk of extrahepatic bileduct cancer after cholecystectomy | Q50185388 | ||
Risk factors for gallbladder cancer. An international collaborative case-control study. | Q53365479 | ||
Expression of cyclooxygenase-1 and -2 in extra-hepatic cholangiocarcinoma. | Q53374054 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 178-180 | |
P577 | publication date | 2008-11-18 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | The antecedents of biliary cancer: a primary care case-control study in the United Kingdom | |
P478 | volume | 100 |
Q41415816 | A review of the impact of obesity on common gastrointestinal malignancies. |
Q39249181 | Aspirin may prevent cholangiocarcinoma: a case-control study from the United kingdom |
Q40873283 | Aspirin use and the risk of cholangiocarcinoma |
Q57485810 | Aspirin use is associated with a reduced risk of cholangiocarcinoma: a systematic review and meta-analysis |
Q91711737 | Atypical presentation of intrahepatic cholangiocarcinoma---Fever and ascites in a postpartum lady |
Q26783050 | Body Mass Index and Risk of Gallbladder Cancer: Systematic Review and Meta-Analysis of Observational Studies |
Q38203734 | Body mass index and biliary tract disease: a systematic review and meta-analysis of prospective studies. |
Q33646525 | CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis |
Q57134289 | Cholangiocarcinoma risk factors and the potential role of aspirin |
Q34000282 | Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China |
Q37855604 | Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis |
Q36243908 | Diabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis |
Q87442270 | Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study |
Q39147308 | Epidemiology and Risk Factors of Cholangiocarcinoma |
Q90005416 | Epidemiology of gallbladder cancer |
Q37851004 | Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer |
Q38812588 | Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). |
Q36966040 | Genetic factors in the pathogenesis of cholangiocarcinoma |
Q40625065 | Healthcare utilization and costs associated with cholangiocarcinoma |
Q37701651 | Interactive role of diabetes mellitus and female sex in the risk of cholangiocarcinoma: A population-based nested case-control study |
Q34398255 | Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors |
Q34874988 | Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control study |
Q33972961 | Meta-analysis of alcohol consumption and risk of extrahepatic bile system cancer |
Q64887814 | Metformin Induces Apoptosis and Inhibits Proliferation through the AMP-Activated Protein Kinase and Insulin-like Growth Factor 1 Receptor Pathways in the Bile Duct Cancer Cells. |
Q35674607 | Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management |
Q36572469 | Obesity and cholangiocarcinoma |
Q53141725 | Obesity and the risk of cholangiocarcinoma: a meta-analysis. |
Q38378989 | Overweight, obesity and the risk of gallbladder and extrahepatic bile duct cancers: A meta-analysis of observational studies |
Q35074664 | Risk factors for cholangiocarcinoma |
Q34186338 | Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates |
Q36589096 | Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk |
Q84476261 | Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications |
Q47141943 | Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysis |
Q92287057 | Smoking, Alcohol, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective Studies |
Q26798443 | Targeted Therapy in Biliary Tract Cancers |
Q37536669 | The association between BMI and gallbladder cancer risk: a meta-analysis |
Q38552233 | The risk factors and diagnosis of cholangiocarcinoma |
Q38537953 | Type 2 diabetes mellitus and risk of gallbladder cancer: a systematic review and meta-analysis of observational studies |
Q45041783 | Type II diabetes mellitus is associated with a reduced risk of cholangiocarcinoma in patients with biliary tract diseases |
Search more.